MGI(SH:688114) Xin Lang Cai Jing·2025-10-29 02:56Core Viewpoint - 华大智造's stock has experienced fluctuations, with a year-to-date increase of 37.23% but a recent decline in the last five trading days by 6.66% [1] Company Overview - Shenzhen Huada Zhizao Technology Co., Ltd. was established on April 13, 2016, and listed on September 9, 2022. The company focuses on the life sciences and biotechnology sectors, specializing in the research, production, and sales of instruments, equipment, and consumables [2] - The main revenue composition includes 90.89% from sales of instruments and consumables, 7.10% from services, and 2.01% from other sources [2] - The company is categorized under the pharmaceutical and biological industry, specifically in medical devices and equipment, with concepts including gene sequencing, synthetic biology, medical devices, and precision medicine [2] Financial Performance - For the period from January to September 2025, Huada Zhizao reported operating revenue of 1.869 billion yuan, a slight decrease of 0.01% year-on-year, while the net profit attributable to shareholders was -120 million yuan, reflecting a significant increase of 74.20% year-on-year [2] - Cumulatively, the company has distributed 150 million yuan in dividends since its A-share listing [3] Shareholder Information - As of September 30, 2025, the number of shareholders increased by 14.17% to 15,400, with an average of 26,794 circulating shares per person, up by 69.94% [2] - The top ten circulating shareholders include various ETFs, with notable reductions in holdings for several funds [3]